Welcome to MedMorphIQ
Accelerating Images to IntelligenceOur Mission
Founded and developed in Austin, TX, MedMorphIQ (powered by US Patent Pending Technology No. 18368348) is committed to bridging the critical global gap between rising cancer cases and limited diagnostic capacity. MedMorphIQ's mission is to harness this momentum and advance diagnostic equity—empowering healthcare professionals with intelligent tools that improve consistency, streamline workflows, and ultimately enhance care for patients worldwide.
Global Shortage
11M healthcare workers projected shortage by 2030 (WHO), especially in pathology.
Manual Bottlenecks
Manual diagnostics can't keep up with rising cancer cases and clinical demand.
Burnout & Variability
Pathologists face burnout, causing variability in diagnostic quality.
AI Momentum
77% of experts believe AI can reduce delays and relieve diagnostic teams (ASCP).
What is MedMorphIQ?
MedMorphIQ is an advanced AI-powered platform designed to revolutionize cancer diagnostics. By combining intelligent automation with expert oversight, MedMorphIQ streamlines tumor analysis, increases diagnostic consistency, and delivers rapid, publication-ready reports. The platform is built to integrate seamlessly into clinical workflows, supporting pathologists and clinicians in making more accurate, efficient, and reproducible decisions for patient care.
Why MedMorphIQ?
Accurate
MedMorphIQ matches the precision of manual counting—the gold standard—without the time burden. In validation, results were statistically indistinguishable from manual methods, supporting clinical accuracy.
Consistent
Our AI algorithms deliver reliable, reproducible results every time. No more variations between different analysts or timestamps.
Fast
Process samples in seconds instead of hours. Our AI accelerates your workflow without compromising on quality.
Contact Us
Email: medmorphiq@gmail.com